The quantification of serum HBsAg titers could add value to HBV DNA quantification and could improve treatment monitoring.[13] Previous studies revealed that serum qAnti-HBc levels are closely related to the host immune status and are strongly associated with hepatitis activity in CHB patients. The gene discussed is KRT88P; the disease is hepatitis A virus infection.